Cargando…
The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC)
Several studies have reported different expression levels of certain genes in NSCLC, mostly related to the stage and advancement of the tumours. We investigated 65 stage I-III NSCLC tumours: 32 adenocarcinomas (ADC), 26 squamous cell carcinomas (SCC) and 7 large cell carcinomas (LCC). Using the real...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SP Versita
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275926/ https://www.ncbi.nlm.nih.gov/pubmed/19238334 http://dx.doi.org/10.2478/s11658-009-0011-7 |
_version_ | 1783377910161211392 |
---|---|
author | Stražišar, Mojca Mlakar, Vid Glavač, Damjan |
author_facet | Stražišar, Mojca Mlakar, Vid Glavač, Damjan |
author_sort | Stražišar, Mojca |
collection | PubMed |
description | Several studies have reported different expression levels of certain genes in NSCLC, mostly related to the stage and advancement of the tumours. We investigated 65 stage I-III NSCLC tumours: 32 adenocarcinomas (ADC), 26 squamous cell carcinomas (SCC) and 7 large cell carcinomas (LCC). Using the real-time reverse transcription polymerase chain reaction (RT-PCR), we analysed the expression of the COX-2, hTERT, MDM2, LATS2 and S100A2 genes and researched the relationships between the NSCLC types and the differences in expression levels. The differences in the expression levels of the LATS2, S100A2 and hTERT genes in different types of NSCLC are significant. hTERT and COX-2 were over-expressed and LATS2 under-expressed in all NSCLC. We also detected significant relative differences in the expression of LATS2 and MDM2, hTERT and MDM2 in different types of NSCLC. There was a significant difference in the average expression levels in S100A2 for ADC and SCC. Our study shows differences in the expression patterns within the NSCLC group, which may mimic the expression of the individual NSCLC type, and also new relationships in the expression levels for different NSCLC types. |
format | Online Article Text |
id | pubmed-6275926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | SP Versita |
record_format | MEDLINE/PubMed |
spelling | pubmed-62759262018-12-10 The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC) Stražišar, Mojca Mlakar, Vid Glavač, Damjan Cell Mol Biol Lett Research Article Several studies have reported different expression levels of certain genes in NSCLC, mostly related to the stage and advancement of the tumours. We investigated 65 stage I-III NSCLC tumours: 32 adenocarcinomas (ADC), 26 squamous cell carcinomas (SCC) and 7 large cell carcinomas (LCC). Using the real-time reverse transcription polymerase chain reaction (RT-PCR), we analysed the expression of the COX-2, hTERT, MDM2, LATS2 and S100A2 genes and researched the relationships between the NSCLC types and the differences in expression levels. The differences in the expression levels of the LATS2, S100A2 and hTERT genes in different types of NSCLC are significant. hTERT and COX-2 were over-expressed and LATS2 under-expressed in all NSCLC. We also detected significant relative differences in the expression of LATS2 and MDM2, hTERT and MDM2 in different types of NSCLC. There was a significant difference in the average expression levels in S100A2 for ADC and SCC. Our study shows differences in the expression patterns within the NSCLC group, which may mimic the expression of the individual NSCLC type, and also new relationships in the expression levels for different NSCLC types. SP Versita 2009-02-23 /pmc/articles/PMC6275926/ /pubmed/19238334 http://dx.doi.org/10.2478/s11658-009-0011-7 Text en © © Versita Warsaw and Springer-Verlag Berlin Heidelberg 2009 |
spellingShingle | Research Article Stražišar, Mojca Mlakar, Vid Glavač, Damjan The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC) |
title | The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC) |
title_full | The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC) |
title_fullStr | The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC) |
title_full_unstemmed | The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC) |
title_short | The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC) |
title_sort | expression of cox-2, htert, mdm2, lats2 and s100a2 in different types of non-small cell lung cancer (nsclc) |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275926/ https://www.ncbi.nlm.nih.gov/pubmed/19238334 http://dx.doi.org/10.2478/s11658-009-0011-7 |
work_keys_str_mv | AT strazisarmojca theexpressionofcox2htertmdm2lats2ands100a2indifferenttypesofnonsmallcelllungcancernsclc AT mlakarvid theexpressionofcox2htertmdm2lats2ands100a2indifferenttypesofnonsmallcelllungcancernsclc AT glavacdamjan theexpressionofcox2htertmdm2lats2ands100a2indifferenttypesofnonsmallcelllungcancernsclc AT strazisarmojca expressionofcox2htertmdm2lats2ands100a2indifferenttypesofnonsmallcelllungcancernsclc AT mlakarvid expressionofcox2htertmdm2lats2ands100a2indifferenttypesofnonsmallcelllungcancernsclc AT glavacdamjan expressionofcox2htertmdm2lats2ands100a2indifferenttypesofnonsmallcelllungcancernsclc |